Nonprescription medicinal products, which include over-the-counter and some homeopathic and herbal medicines, comprise a large part of the pharmaceutical market in Germany, accounting for 35% of all sales in 1992. This paper reviews definitions, markets, the legal framework, and future prospects. It covers the role of the Federal Health Office in ensuring the quality, safety, and efficacy of all medicinal products sold in Germany.
KellerK. Legal requirements for the use of phytopharmaceutical drugs in the Federal Republic of Germany. J Ethnopharmacol. 1991;32:225–229.
2.
KellerK. Der rechtliche Status homöopathischer Arzneimittel. Tierärztl Prax. 1992;20:243–247.
3.
KellerK. Naturheilmittel und Besondere Therapierichtungen. Bundesgesundheitsblatt. 1990;33:297–301.
4.
PayerL. Medicines and culture. Varieties of Treatment in the United States, England, West Germany, and France. New York: Henry Holt & Co. Inc.; 1988.
5.
Holz-SlomczykM. Criteria for the Revision of the so-called Old Drugs in the Federal Republic of Germany. Drugs made in Germany. 1990;33:115–117.
6.
KellerK. Results of the revision of herbal drugs in the Federal Republic of Germany with a special focus on risk aspects. Ztschr Phytotherapie. 1992;13:116–120.
